TVARDI THERAPEUTICS, INC. Increase (Decrease) in Contract with Customer, Liability
TVARDI THERAPEUTICS, INC. (TVRD) reported Increase (Decrease) in Contract with Customer, Liability of -$22.26 million for the 12-month period ending 2020-12-31, per its 10-K filed 2023-03-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2023-03-06
- TVARDI THERAPEUTICS, INC. increase (decrease) in contract with customer, liability for the quarter ending 2020-12-31 was -$511.00K.
- TVARDI THERAPEUTICS, INC. increase (decrease) in contract with customer, liability for the quarter ending 2020-09-30 was -$9.26M.
- TVARDI THERAPEUTICS, INC. increase (decrease) in contract with customer, liability for the quarter ending 2020-06-30 was -$4.47M.
- TVARDI THERAPEUTICS, INC. increase (decrease) in contract with customer, liability for the quarter ending 2020-03-31 was -$8.02M.
- TVARDI THERAPEUTICS, INC. increase (decrease) in contract with customer, liability for fiscal 2020 was -$22.26M.
- TVARDI THERAPEUTICS, INC. increase (decrease) in contract with customer, liability for fiscal 2019 was -$19.75M, a 147.01% decline from fiscal 2018.
- TVARDI THERAPEUTICS, INC. increase (decrease) in contract with customer, liability for fiscal 2018 was $42.01M.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2020-12-31 | -$511.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | -$9.77M derived: sum of 2 quarters · filed 2023-03-06 | -$14.24M derived: sum of 3 quarters · filed 2023-03-06 | -$22.26M 10-K · filed 2023-03-06 |
| 2020-09-30 | -$9.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$13.73M derived: sum of 2 quarters · filed 2021-11-08 | -$21.75M 10-Q · filed 2021-11-08 | -$26.26M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | -$4.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$12.49M 10-Q · filed 2021-08-09 | -$17.01M derived: sum of 3 quarters · filed 2022-03-01 | -$22.79M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | -$8.02M 10-Q · filed 2021-05-10 | -$12.53M derived: sum of 2 quarters · filed 2022-03-01 | -$18.32M derived: sum of 3 quarters · filed 2022-03-01 | -$23.53M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | -$4.51M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$10.30M derived: sum of 2 quarters · filed 2022-03-01 | -$15.51M derived: sum of 3 quarters · filed 2022-03-01 | -$19.75M 10-K · filed 2022-03-01 |
| 2019-09-30 | -$5.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$10.99M derived: sum of 2 quarters · filed 2020-11-09 | -$15.23M 10-Q · filed 2020-11-09 | -$20.77M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | -$5.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$9.45M 10-Q · filed 2020-08-10 | -$14.98M derived: sum of 3 quarters · filed 2021-02-25 | -$20.01M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | -$4.24M 10-Q · filed 2020-05-11 | -$9.78M derived: sum of 2 quarters · filed 2021-02-25 | -$14.80M derived: sum of 3 quarters · filed 2021-02-25 | |
| 2018-12-31 | -$5.53M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$10.56M derived: sum of 2 quarters · filed 2021-02-25 | $42.01M 10-K · filed 2021-02-25 | |
| 2018-09-30 | -$5.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $47.54M 10-Q · filed 2019-11-05 | ||
| 2018-06-30 | $52.57M 10-Q · filed 2019-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |